Infectious Diseases News and Research

RSS

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Sinovac Biotech Ltd., a leading provider of vaccines in China, announced today that Fengcai Zhu, Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, presented data regarding Sinovac's proprietary enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease at the 13th Annual World Vaccine Congress & Expo, taking place from April 16-18, 2013, in Washington D.C.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

Antibiotic resistance: A growing problem in hospital and outpatient settings

A new study concludes that problems with antibiotic resistance faced by outpatients may be as bad as those in hospitalized patients, and that more studies of outpatients are needed - both to protect their health and to avoid inappropriate or unnecessary drug use.

19 Apr 2013

Dr. Jeffrey Maisels honored as 2013 Legends of Neonatology Hall of Fame inductee

M. Jeffrey Maisels, M.D., was honored as a 2013 Legends of Neonatology Hall of Fame inductee. He was chosen for a career spanning 47 years of clinical care and research involving management of the jaundiced newborn infant.

18 Apr 2013

Zambia, Zimbabwe address TB/HIV co-infection

The Center for Global Health Policy's "Science Speaks" blog outlines efforts to fight TB/HIV co-infection in Zambia and Zimbabwe.

18 Apr 2013

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.

18 Apr 2013

H7N9 virus continues to spread; International research team traveling to China to assist

"Two more people in China have died from a new strain of avian influenza, bringing to 16 the number of deaths from the H7N9 virus, and the government has warned that the number of infections could rise," Reuters reports.

18 Apr 2013

CRISPR helps some bacteria evade mammalian immune system

CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.

18 Apr 2013

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid Drug Platform.

18 Apr 2013

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

tem cells and tissue-specific cells can be grown in abundance from mature mammalian cells simply by blocking a certain membrane protein, according to scientists at the University of Pittsburgh School of Medicine and the National Institutes of Health.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Research findings could lead to novel approaches for eliminating reservoirs of HIV-1

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated.

18 Apr 2013

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

BioLineRx, a biopharmaceutical development company, announced today positive Phase IIa results for BL-7040, an orally available drug for treating inflammatory bowel disease.

17 Apr 2013

Research shows how climate, environmental changes influence spread of dangerous viruses

How are human and animal diseases in general affected by the climate becoming "wilder, wetter and warmer"? Solveig Jore's doctoral research shows that the tick Ixodes ricinus has spread over larger geographical areas in Norway and that climate and environmental changes, access to host animals and demography affect tick distribution in Norway.

17 Apr 2013

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

Studies have shown that about 10 percent of men infected with human immunodeficiency virus have an elevated resting energy expenditure.

17 Apr 2013

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.

17 Apr 2013

New generation of innovative medical devices to be created by Curie-Cancer and Vygon partnership

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.

16 Apr 2013

Pakistani Taliban deny responsibility for attacks on polio workers

"The Pakistani Taliban on Friday denied any involvement in attacks on polio workers, which have killed 21 people since December, but confirmed it opposed the vaccination as 'un-Islamic,'" Agence France-Presse reports.

16 Apr 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Malaria control strategies must adapt to rapidly changing patterns of infection

Malaria control strategies must keep up with the rapidly changing patterns of malaria infection in low transmission settings, according to the authors of a new Review, published in The Lancet. Whereas women and young children suffer from the greatest burden of malaria in high transmission areas, an increasing proportion of malaria cases in low transmission settings are occurring in adult men, sometimes concentrated in small geographic areas and sharing certain occupations or behaviours.

15 Apr 2013

Infectious Diseases News and Research

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Antibiotic resistance: A growing problem in hospital and outpatient settings

Dr. Jeffrey Maisels honored as 2013 Legends of Neonatology Hall of Fame inductee

Zambia, Zimbabwe address TB/HIV co-infection

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

H7N9 virus continues to spread; International research team traveling to China to assist

CRISPR helps some bacteria evade mammalian immune system

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Research findings could lead to novel approaches for eliminating reservoirs of HIV-1

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

Research shows how climate, environmental changes influence spread of dangerous viruses

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

New generation of innovative medical devices to be created by Curie-Cancer and Vygon partnership

Pakistani Taliban deny responsibility for attacks on polio workers

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Malaria control strategies must adapt to rapidly changing patterns of infection

eBook: Advancing infectious disease vaccine development eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News